background logo image

Episode 217

David Baszucki: What My Son's Recovery Taught Me About Mental Illness

Listen, Watch & Subscribe on:

Watch

David Baszucki: What My Son's Recovery Taught Me About Mental Illness

Listen

About the host

David Baszucki

David Baszucki

Co-Founder, Baszucki Group

David Baszucki

Co-Founder, Baszucki Group

David is the founder and CEO of Roblox, a global platform where millions of people around the world gather together every day to imagine, create and share experiences with each other in immersive, user-generated 3D worlds. Pioneering the category of virtual human co-experience, Roblox became a publicly traded company on the New York Stock Exchange in March of 2021. David has committed any additional compensation he receives as CEO toward philanthropic purposes.

Alongside Jan Ellison Baszucki, David has funded neuropsychiatric research for many years. Together, they launched Baszucki Group in 2021 to propel and expand this work and to address societal change in other areas. David co-directs Baszucki Group’s philanthropic investment strategy, with particular interests in metabolic health, democracy and astronomy. David and Jan have four adult children and live in the San Francisco Bay Area.

Originally from Canada, David grew up in Eden Prairie, Minnesota, where he spent time outdoors riding dirt bikes and building go-karts. As a child, he liked to read the encyclopedia, and he enjoyed science fiction novels that transported him to different worlds. In high school, he led his school’s quiz bowl team and played saxophone in the all-state band. David studied electrical engineering and computer science at Stanford, where he became a General Motors Scholar. He spent two summers in Flint, Michigan, as an intern at Buick product engineering.

Prior to Roblox, David, Erik Cassel, and his brother, Greg, founded Knowledge Revolution in the late 1980s. They created “Interactive Physics,” a leading educational physics software package. The company later built a 3D mechanical engineering simulator for companies producing a range of products, from cars to cameras to farm equipment to copy machines. Knowledge Revolution was acquired by MSC Software Corporation, and after several years, David left to pursue other interests.

David dabbled in angel investing, hosted his own talk radio show, and crossed the Western U.S. and Canada in a motorhome with Jan and their children. Returning home, David was joined by Erik Cassel, who had been the lead engineer at Knowledge Revolution, in a one-room office in Menlo Park. They began writing the simulation code that would ultimately become the foundation of Roblox. Erik died of cancer in 2013. David continues the work of Roblox in Erik’s memory.

Learn more about David

About the host

Iain Campbell

Iain Campbell

Baszucki Metabolic Psychiatry Research Fellow

Iain Campbell

Baszucki Metabolic Psychiatry Research Fellow

Dr. lain Campbell is the Baszucki Research Fellow in Metabolic Psychiatry at the University of Edinburgh where he completed his PhD in Global Health. He lives with Bipolar Disorder Type 2 which informs his work from lived experience.

About the host

Matthew Baszucki

Matthew Baszucki

Speaker, Advocate

Matthew Baszucki

Speaker, Advocate

Healed bipolar disorder with a ketogenic diet, sleep hygiene, physical exercise, and other metabolic health strategies. Now his mission to share his story with the world and help others recover.
Learn more about Matthew

About the host

David Baszucki

David Baszucki

Co-Founder, Baszucki Group

David Baszucki

Co-Founder, Baszucki Group

David is the founder and CEO of Roblox, a global platform where millions of people around the world gather together every day to imagine, create and share experiences with each other in immersive, user-generated 3D worlds. Pioneering the category of virtual human co-experience, Roblox became a publicly traded company on the New York Stock Exchange in March of 2021. David has committed any additional compensation he receives as CEO toward philanthropic purposes.

Alongside Jan Ellison Baszucki, David has funded neuropsychiatric research for many years. Together, they launched Baszucki Group in 2021 to propel and expand this work and to address societal change in other areas. David co-directs Baszucki Group’s philanthropic investment strategy, with particular interests in metabolic health, democracy and astronomy. David and Jan have four adult children and live in the San Francisco Bay Area.

Originally from Canada, David grew up in Eden Prairie, Minnesota, where he spent time outdoors riding dirt bikes and building go-karts. As a child, he liked to read the encyclopedia, and he enjoyed science fiction novels that transported him to different worlds. In high school, he led his school’s quiz bowl team and played saxophone in the all-state band. David studied electrical engineering and computer science at Stanford, where he became a General Motors Scholar. He spent two summers in Flint, Michigan, as an intern at Buick product engineering.

Prior to Roblox, David, Erik Cassel, and his brother, Greg, founded Knowledge Revolution in the late 1980s. They created “Interactive Physics,” a leading educational physics software package. The company later built a 3D mechanical engineering simulator for companies producing a range of products, from cars to cameras to farm equipment to copy machines. Knowledge Revolution was acquired by MSC Software Corporation, and after several years, David left to pursue other interests.

David dabbled in angel investing, hosted his own talk radio show, and crossed the Western U.S. and Canada in a motorhome with Jan and their children. Returning home, David was joined by Erik Cassel, who had been the lead engineer at Knowledge Revolution, in a one-room office in Menlo Park. They began writing the simulation code that would ultimately become the foundation of Roblox. Erik died of cancer in 2013. David continues the work of Roblox in Erik’s memory.

Learn more about David

About the host

Iain Campbell

Iain Campbell

Baszucki Metabolic Psychiatry Research Fellow

Iain Campbell

Baszucki Metabolic Psychiatry Research Fellow

Dr. lain Campbell is the Baszucki Research Fellow in Metabolic Psychiatry at the University of Edinburgh where he completed his PhD in Global Health. He lives with Bipolar Disorder Type 2 which informs his work from lived experience.

About the host

Matthew Baszucki

Matthew Baszucki

Speaker, Advocate

Matthew Baszucki

Speaker, Advocate

Healed bipolar disorder with a ketogenic diet, sleep hygiene, physical exercise, and other metabolic health strategies. Now his mission to share his story with the world and help others recover.
Learn more about Matthew

Key Highlights

  • David Baszucki recounts the family’s most frightening experience: tracking down his son Matt, then deep in a manic episode, living homeless on the streets of Los Angeles after a multi-day hike left him with only a laptop and a Safeway bag.
  • Through a carefully coordinated, respectful approach involving cigarettes, a promised steak dinner, and a trusted uncle, the family successfully got Matt to voluntarily check into a psychiatric hospital, a pivotal turning point in his recovery.
  • Despite trying over 20 different medications and being told by doctors that Matt would likely need heavy medication for life, none of his healthcare providers ever mentioned trying a ketogenic diet as a potential treatment.
  • After Matt’s mother, Jan, found and pushed for ketogenic therapy, Matt experienced dramatic improvement, motivating the family to found Baszucki Group and help launch what has become a growing global field of metabolic psychiatry research.
  • Both Matt and David encourage families facing similar mental health crises not to give up, to seek multiple medical opinions, and to consider exploring metabolic approaches like ketogenic therapy under professional guidance.

Transcript

Listen, Watch & Subscribe on:

You May Also Be Interested In:

Metformin, Insulin Resistance and Bipolar Depression: From Research to Clinical Care
Podcast

Metformin, Insulin Resistance and Bipolar Depression: From Research to Clinical Care

In this episode of the Metabolic Mind Podcast, Dr. Bret Scher talks with metabolic psychiatrist Dr. Cynthia Calkin about her landmark TRIO-BD study, which shows that treating insulin resistance with metformin can rapidly improve long-standing, treatment-resistant bipolar depression. Calkin explains how people with bipolar disorder have dramatically higher rates of insulin resistance, obesity, and blood–brain barrier leakage—and how targeting these metabolic problems can restore mood, function, and quality of life, sometimes after decades of failed treatments. The conversation explores the emerging field of metabolic psychiatry, the role of metformin and other insulin-sensitizing strategies, and the promise of diet and lifestyle (including ketogenic-style approaches) as powerful tools for conditions like bipolar disorder, PTSD, and major depression.

Read more

Bipolar I vs. Bipolar II: Key Differences, Symptoms & Treatments Explained
Perspectives in Metabolic Psychiatry

Bipolar I vs. Bipolar II: Key Differences, Symptoms & Treatments Explained

A Nuanced Guide to Understanding Bipolar Mood Disorders, Why They’re Often Misdiagnosed, and How Personalized Treatment Is Reshaping Lives. Bipolar mood disorders are complex and often misunderstood mental…

Learn more

new bipolar disorder study
News

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

“For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the participants in a new pilot study…

Learn more

Treating Bipolar with Keto – 100 Self-Reports with Dr. Iain Campbell
Podcast

Treating Bipolar with Keto – 100 Self-Reports with Dr. Iain Campbell

Can ketogenic therapy help stabilize bipolar disorder—especially the hard-to-treat depressive side? In this Metabolic Mind episode, Dr. Bret Scher sits down with Dr. Iain Campbell, a Baszucki Brain Research Fellow at the University of Edinburgh who also lives with bipolar II. Campbell shares results from a first-of-its-kind online survey of more than 100 people using ketogenic diets for bipolar disorder: many report substantial improvements, extended remissions (some lasting years), and marked reductions in depression and suicidal thinking. He also previews data from a pilot study of 27 participants showing that higher blood ketone levels correlate with better mood, energy, and lower anxiety—especially above ~2.0 mmol/L—and that objective markers shift in a therapeutic direction, including reduced brain glutamate (on MRS) and lower serum lactate, consistent with improved mitochondrial function. While the team is clear about limitations (self-selection, not a randomized trial), the qualitative stories are powerful, and the quantitative signals are promising. Campbell outlines what’s next: a randomized controlled trial and a new metabolic psychiatry research hub in Edinburgh to accelerate rigorous science. If you’re curious about the intersection of ketosis and serious mental illness—or you’re a clinician looking for emerging, adjunctive tools—this conversation offers data, mechanisms, and lived experience in one place.

Learn more

Metformin, Insulin Resistance and Bipolar Depression: From Research to Clinical Care
Podcast

Metformin, Insulin Resistance and Bipolar Depression: From Research to Clinical Care

In this episode of the Metabolic Mind Podcast, Dr. Bret Scher talks with metabolic psychiatrist Dr. Cynthia Calkin about her landmark TRIO-BD study, which shows that treating insulin resistance with metformin can rapidly improve long-standing, treatment-resistant bipolar depression. Calkin explains how people with bipolar disorder have dramatically higher rates of insulin resistance, obesity, and blood–brain barrier leakage—and how targeting these metabolic problems can restore mood, function, and quality of life, sometimes after decades of failed treatments. The conversation explores the emerging field of metabolic psychiatry, the role of metformin and other insulin-sensitizing strategies, and the promise of diet and lifestyle (including ketogenic-style approaches) as powerful tools for conditions like bipolar disorder, PTSD, and major depression.

Read more

Bipolar I vs. Bipolar II: Key Differences, Symptoms & Treatments Explained
Perspectives in Metabolic Psychiatry

Bipolar I vs. Bipolar II: Key Differences, Symptoms & Treatments Explained

A Nuanced Guide to Understanding Bipolar Mood Disorders, Why They’re Often Misdiagnosed, and How Personalized Treatment Is Reshaping Lives. Bipolar mood disorders are complex and often misunderstood mental…

Learn more

new bipolar disorder study
News

New Bipolar Disorder Study Shows that a Ketogenic Diet Leads to Mental and Physical Health Benefits

“For the first time in years, I felt like my brain was finally running on the right fuel,” said one of the participants in a new pilot study…

Learn more

Treating Bipolar with Keto – 100 Self-Reports with Dr. Iain Campbell
Podcast

Treating Bipolar with Keto – 100 Self-Reports with Dr. Iain Campbell

Can ketogenic therapy help stabilize bipolar disorder—especially the hard-to-treat depressive side? In this Metabolic Mind episode, Dr. Bret Scher sits down with Dr. Iain Campbell, a Baszucki Brain Research Fellow at the University of Edinburgh who also lives with bipolar II. Campbell shares results from a first-of-its-kind online survey of more than 100 people using ketogenic diets for bipolar disorder: many report substantial improvements, extended remissions (some lasting years), and marked reductions in depression and suicidal thinking. He also previews data from a pilot study of 27 participants showing that higher blood ketone levels correlate with better mood, energy, and lower anxiety—especially above ~2.0 mmol/L—and that objective markers shift in a therapeutic direction, including reduced brain glutamate (on MRS) and lower serum lactate, consistent with improved mitochondrial function. While the team is clear about limitations (self-selection, not a randomized trial), the qualitative stories are powerful, and the quantitative signals are promising. Campbell outlines what’s next: a randomized controlled trial and a new metabolic psychiatry research hub in Edinburgh to accelerate rigorous science. If you’re curious about the intersection of ketosis and serious mental illness—or you’re a clinician looking for emerging, adjunctive tools—this conversation offers data, mechanisms, and lived experience in one place.

Learn more